Application of CRISPR-Cas9 for the Prevention and Treatment of HIV-1 Prevention
DOI:
https://doi.org/10.47611/jsrhs.v12i3.4473Keywords:
CRISPR, HIV, Shock-and-Kill, CCR5 Coreceptor, HSCAbstract
Human immunodeficiency virus, also known as HIV, is a virus that attacks the body’s immune system. As of today, the virus is prevalent, particularly across the United States and Sub-Saharan Africa [23]. There are treatments in place for the prevention of HIV, however, for those who are HIV/AIDS positive there’s still a long way to go in terms of developing treatments to cure the disease entirely. In this review, we will cover how CRISPR-Cas9 can be used to treat HIV-1 thereby overcoming limitations of existing treatments. For example, while highly active antiretroviral therapy (HAART) is used to suppress HIV’s replication process, it cannot cure HIV as it cannot target inactive HIV-1. CRISPR-Cas9 could treat latent HIV-1 infection by editing out the viral DNA in the host’s genome, removing the co-receptors of the host cell, genetically modifying HSC cells, and combining the use of CRISPR-Cas9 with “Shock and Kill.” However, while these methods of preventing and treating HIV-1 do show promise, they will need to be further developed with biological limitations in mind which will be covered in this review. In addition to biological limitations, moral and ethical concerns are present as CRISPR-Cas9 introduces designer babies with somatically edited genes, super-humans, and malignant mutations, these considerations will be covered in the discussion.
Downloads
References or Bibliography
About HIV/AIDS | HIV Basics | HIV/AIDS | CDC. (2022, June 30). https://www.cdc.gov/hiv/basics/whatishiv.html
Binda, C. S., Klaver, B., Berkhout, B., & Das, A. T. (2020). CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA. Viruses, 12(3), 330. https://doi.org/10.3390/v12030330
Burke, D. S. (1997). Recombination in HIV: An important viral evolutionary strategy. Emerging Infectious Diseases, 3(3), 253–259. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627633/
CD4 Lymphocyte Count: MedlinePlus Medical Test. (n.d.). Retrieved March 31, 2023, from https://medlineplus.gov/lab-tests/cd4-lymphocyte-count/
Darcis, G., Das, A. T., & Berkhout, B. (2018). Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies. Viruses, 10(4), 157. https://doi.org/10.3390/v10040157
Das, A. T., Binda, C. S., & Berkhout, B. (2019). Elimination of infectious HIV DNA by CRISPR–Cas9. Current Opinion in Virology, 38, 81–88. https://doi.org/10.1016/j.coviro.2019.07.001
Frontiers | Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy. (n.d.). Retrieved March 31, 2023, from https://doi.org/10.3389/fcimb.2019.00069
Gulzar, N., & Copeland, K. F. T. (n.d.). CD8+ T-Cells: Function and Response to HIV Infection. Current HIV Research, 2(1), 23–37. https://pubmed.ncbi.nlm.nih.gov/15053338/
Heeren, F., & J, J. (2022). Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV. BioTech, 11(3), Article 3. https://doi.org/10.3390/biotech11030025
HIV & AIDS Trends and U.S. Statistics Overview. (n.d.). HIV.Gov. Retrieved March 31, 2023, from https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics
HIV/AIDS - Symptoms and causes. (n.d.). Mayo Clinic. Retrieved March 31, 2023, from https://www.mayoclinic.org/diseases-conditions/hiv-aids/symptoms-causes/syc-20373524
Kim, B., Kim, H. J., & Lee, S. J. (2020). Regulation of Microbial Metabolic Rates Using CRISPR Interference With Expanded PAM Sequences. Frontiers in Microbiology, 11. https://doi.org/10.3389/fmicb.2020.00282
Kindberg, E., Mickienė, A., Ax, C., Åkerlind, B., Vene, S., Lindquist, L., Lundkvist, Å., & Svensson, L. (2008). A Deletion in the Chemokine Receptor 5 (CCR5) Gene Is Associated with Tickborne Encephalitis. The Journal of Infectious Diseases, 197(2), 266–269. https://doi.org/10.1086/524709
Lee, J. Y., & Hong, S.-H. (2019). Hematopoietic Stem Cells and Their Roles in Tissue Regeneration. International Journal of Stem Cells, 13(1), 1–12. https://doi.org/10.15283/ijsc19127
Lim, J. K., Louie, C. Y., Glaser, C., Jean, C., Johnson, B., Johnson, H., McDermott, D. H., & Murphy, P. M. (2008). Genetic Deficiency of Chemokine Receptor CCR5 Is a Strong Risk Factor for Symptomatic West Nile Virus Infection: A Meta-Analysis of 4 Cohorts in the US Epidemic. The Journal of Infectious Diseases, 197(2), 262–265. https://doi.org/10.1086/524691
Long Terminal Repeat—An overview | ScienceDirect Topics. (n.d.). Retrieved March 31, 2023, from https://www.sciencedirect.com/topics/medicine-and-dentistry/long-terminal-repeat
Luther, D. C., Lee, Y. W., Nagaraj, H., Scaletti, F., & Rotello, V. M. (2018). Delivery Approaches for CRISPR/Cas9 Therapeutics In Vivo: Advances and Challenges. Expert Opinion on Drug Delivery, 15(9), 905–913. https://doi.org/10.1080/17425247.2018.1517746
Mao, Z., Bozzella, M., Seluanov, A., & Gorbunova, V. (2008). DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle (Georgetown, Tex.), 7(18), 2902–2906. https://doi.org/10.4161/cc.7.18.6679
Mohamed, H., Gurrola, T., Berman, R., Collins, M., Sariyer, I. K., Nonnemacher, M. R., & Wigdahl, B. (2022). Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.816515
Müllers, E. (2013). The Foamy Virus Gag Proteins: What Makes Them Different? Viruses, 5(4), 1023–1041. https://doi.org/10.3390/v5041023
Nyamweya, S., Hegedus, A., Jaye, A., Rowland-Jones, S., Flanagan, K. L., & Macallan, D. C. (2013). Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis. Reviews in Medical Virology, 23(4), 221–240. https://doi.org/10.1002/rmv.1739
RNA Polymerase II - an overview | ScienceDirect Topics. (n.d.). Retrieved March 31, 2023, from https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/rna-polymerase-ii
Roser, M., & Ritchie, H. (2018). HIV / AIDS. Our World in Data. https://ourworldindata.org/hiv-aids
Stern, A., & Sorek, R. (2011). The phage-host arms race: Shaping the evolution of microbes. BioEssays, 33(1), 43–51. https://doi.org/10.1002/bies.201000071
The ethical debate around Crispr | Opinion | Chemistry World. (n.d.). Retrieved March 31, 2023, from https://www.chemistryworld.com/opinion/the-ethical-debate-around-crispr/4012573.article
Thurtle-Schmidt, D. M., & Lo, T.-W. (2018). Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates. Biochemistry and Molecular Biology Education, 46(2), 195–205. https://doi.org/10.1002/bmb.21108
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2016). A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures. Cell Reports, 17(11), 2819–2826. https://doi.org/10.1016/j.celrep.2016.11.057
What is a Latent HIV Reservoir? | NIH. (n.d.). Retrieved March 31, 2023, from https://hivinfo.nih.gov/understanding-hiv/fact-sheets/what-latent-hiv-reservoir
Xun, J., Zhang, X., Guo, S., Lu, H., & Chen, J. (2021). Editing out HIV: Application of gene editing technology to achieve functional cure. Retrovirology, 18(1), 39. https://doi.org/10.1186/s12977-021-00581-1
Zhou, M., Greenhill, S., Huang, S., Silva, T. K., Sano, Y., Wu, S., Cai, Y., Nagaoka, Y., Sehgal, M., Cai, D. J., Lee, Y.-S., Fox, K., & Silva, A. J. (n.d.). CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory. ELife, 5, e20985. https://doi.org/10.7554/eLife.20985
Published
How to Cite
Issue
Section
Copyright (c) 2023 Isaac Kim; Elliote
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
